We’re putting the EMPHASIS back on CELIAC DISEASE .

Beyond Celiac applauds government commitment, encourages applications for these special celiac disease research grants.

Beyond Celiac is shining a spotlight on those who have been “left behind” in the celiac disease world due to missed diagnosis or challenges to diagnosis

How can you take care of your body, mind, and soul all at once? Sign up for our September Step Beyond Celiac 5K of course!

New bill would require all gluten containing grains be disclosed on food packaging ingredient labels

Beyond Celiac Chief Scientist and Strategy Officer, Salvatore Alesci, MD, PhD answers frequently asked questions about celiac disease and COVID-19 vaccines.

The reliability of urine tests to determine how much gluten might be getting into the gluten-free diet is questioned in a new study. Meanwhile other scientists defend the accuracy of the tests based on the results of previous research.

Monoclonal antibodies can be used for treating many different types of disease and are being studied in celiac disease after showing proof-of-concept in earlier trials

If you are Black or have public insurance and also have symptoms associated with celiac disease or inflammatory bowel disease, your chance of getting proper follow-up for diagnosis is greatly reduced, a recent study found.

Children who had no symptoms but were diagnosed with celiac disease as part of a mass pediatric screening program reported a better quality of life overall after a year on the gluten-free diet, preliminary results of a study funded by Beyond Celiac show.

An international group of researchers are investigating a monoclonal antibody that has the potential to treat celiac disease by stopping the activation of cells that identify gluten as an invader.

Ask a Dietitian: What are dietary supplements you would recommend for a patient diagnosed with celiac disease?

Foods for when you suffer from both celiac disease and diverticulitis

Monitoring celiac disease

How to tell if ongoing symptoms are from celiac disease

What’s the point of follow-up testing and monitoring?

Monoclonal antibodies can be used for treating many different types of disease and are being studied in celiac disease after showing proof-of-concept in earlier trials

PRV-015 has previously been studied for its potential to reduce symptoms and inflammation triggered by gluten in people with celiac disease.

Latiglutenase development continues with initial CeliacShield™ study results and ongoing Solutions for Celiac™ clinical study actively recruiting participants

Celiac disease community is an integral part of research into this potential immune tolerance treatment

Recruitment of symptomatic participants in the first celiac disease Phase 3 clinical trial continues